Exploring the Feasibility of Estrogen Replacement Therapy as a Treatment for Perimenopausal Depression: A Comprehensive Literature Review.
Xiuting XiangPraneetha PalasuberniamRahmawati ParePublished in: Medicina (Kaunas, Lithuania) (2024)
Perimenopausal depression (PMD) is a psychological disorder that occurs in women during perimenopause. In addition to the common clinical symptoms of depression, it often manifests as a perimenopausal complication, and its notable cause is the decline in estrogen levels. Despite numerous studies and trials confirming the benefits of estrogen replacement therapy (ERT) for PMD, ERT remains unapproved for treating PMD. Therefore, we conducted a literature search using selected keywords in PubMed and Google Scholar to write a review discussing the feasibility of using ERT for PMD. This review examines the potential of ERT for PMD in terms of its underlying mechanisms, efficacy, safety, and time window. These four aspects suggest that ERT is a viable option for PMD treatment. However, the risk of thrombosis and stroke with ERT is a matter of contention among medical experts, with a paucity of clinical data. Consequently, further clinical trial data are required to ascertain the safety of ERT.
Keyphrases
- replacement therapy
- smoking cessation
- sleep quality
- clinical trial
- postmenopausal women
- depressive symptoms
- estrogen receptor
- systematic review
- big data
- electronic health record
- pulmonary embolism
- polycystic ovary syndrome
- type diabetes
- atrial fibrillation
- pregnant women
- open label
- skeletal muscle
- machine learning
- randomized controlled trial
- metabolic syndrome
- phase ii
- human health
- brain injury
- placebo controlled
- subarachnoid hemorrhage
- double blind